| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |